Immunoassay Market Growth To $52.83 Billion By 2030: What’s Driving The Expansion?
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Immunoassay Market Size, Value And Growth Trajectory Through 2030
The immunoassay market has experienced substantial growth in recent years. It is projected to expand from $37.32 billion in 2025 to $40.07 billion in 2026, registering a compound annual growth rate (CAGR) of 7.4%. The expansion observed historically can be ascribed to the increasing prevalence of infectious and chronic diseases, higher volumes of clinical laboratory testing, the broad adoption of ELISA-based diagnostics, growth in pharmaceutical research activities, and a rising demand for early disease detection.
The immunoassay market is set to experience substantial expansion over the next few years. Its valuation is projected to reach $52.83 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 7.2%. This growth during the forecast period is primarily driven by factors such as the escalating demand for rapid diagnostics, increased investments in personalized medicine, the expansion of decentralized testing models, a wider adoption of digital laboratory workflows, and a greater focus on companion diagnostics. Significant trends anticipated in this period encompass the growing acceptance of high-sensitivity immunoassay kits, the increased utilization of automated immunoassay analyzers, rising demand for point-of-care immunoassay testing, the expansion of multiplex immunoassay platforms, and improved integration of data management software.
Get A Free Sample Report With In-Depth Market Insights:
Immunoassay Market Opportunity Drivers: What’s Unlocking New Revenue Potential?
The immunoassay market is anticipated to experience growth due to the escalating numbers of infectious and chronic illnesses. These refer to diseases caused by pathogens or enduring medical conditions that demand continuous monitoring, diagnosis, and management. The rise in infectious and chronic illnesses is attributed to increased exposure to environmental pollutants, which compromise immunity and elevate vulnerability to disease. The immunoassay market is seeing heightened demand as the swift increase in these illnesses prompts companies to integrate advanced diagnostic tools crucial for early detection, disease surveillance, and precise clinical decision-making. For instance, in June 2025, the UK Health Security Agency (UKHSA), a United Kingdom-based government public health agency, indicated that reported Campylobacter cases in England climbed from 60,055 in 2023 to 70,352 cases in 2024, marking a rise of 10,297 cases (17.1%) and an increase in the reporting rate from 104.1 to 121.9 per 100,000 population. Therefore, the expanding prevalence of infectious and chronic illnesses is a significant driver for the immunoassay market.
Immunoassay Market Segmentation: How Does The Market Break Down By Category?
The immunoassay market covered in this report is segmented –
1) By Product: Reagents And Kits, Analyzers Or Instruments, Software And Services
2) By Specimen: Blood, Saliva, Urine, Other Specimens
3) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications
4) By End User: Research And Academic Laboratories, Pharmaceutical And Biotechnology Companies And CROs, Hospitals And Clinics, Clinical Laboratories
Subsegments:
1) By Reagents And Kits: ELISA Kits, Rapid Test Kits, Control Reagents, Assay Development Reagents
2) By Analyzers Or Instruments: Automated Analyzers, Point-Of-Care Testing Devices, Microplate Readers, Luminometers
3) By Software And Services: Data Management Software, Analytical Software, Support And Maintenance Services, Consulting Services
Immunoassay Market Innovation Trends Shaping Future Development
Leading companies in the immunoassay market are launching innovative immunoassay analyzers to secure a competitive advantage. Immunoassay analyzers are laboratory instruments designed to automate and simplify the detection and measurement of biological molecules, such as proteins or hormones, through immunological reactions. For example, in May 2023, Beckman Coulter Diagnostics, a US-based firm that develops products to simplify, automate, and innovate complex biomedical testing, introduced the DxI 9000 Access Immunoassay Analyzer. The DxI 9000 Access Immunoassay Analyzer addresses clinical laboratories’ needs for speed, reliability, reproducibility, quality, and an expanded test menu. It has demonstrated the capacity to develop increasingly sensitive and clinically relevant assays, thereby amplifying the effectiveness of new pharmaceutical therapies and ultimately improving patient health outcomes. This system incorporates innovations such as advanced analyte processing and detection technology, precision sensors, intelligent algorithms, and remote real-time system monitoring, making it the only immunoassay analyzer system that does not require daily maintenance.
Immunoassay Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the immunoassay market are Siemens Healthineers GmbH, bioMérieux, Abbott, Beckman Coulter Inc., Quidel Corporation, Ortho Clinical Diagnostics, Sysmex Corporation, Bio-Rad Laboratories Inc., Becton Dickinson and Company, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc, WAK-Chemie Medical GmbH, J Mitra & Co Pvt Ltd, Kamiya Biomedical Company, Tosoh Corporation, Gyros Protein Technologies AB, BioCheck Inc., Bio-Techn, DiaSorin S.p.A, Meso Scale Diagnostics LLC, QIAGE, Randox Laboratories Ltd., Shenzhen Mindray Bio-Medical Electronics Co Ltd, Danaher Corporation, Hologic Inc., Tecan Trading AG, Eurofins Scientific, Abcam plc, Enzo Biochem Inc., Luminex Corporation, Quanterix Corporation, Roche Diagnostics, ZEUS Scientific Inc.
View The Full Immunoassay Market Report:
Immunoassay Market Geographic Spread And Regional Opportunities
North America was the largest region in the immunoassay market in 2025. Asia-Pacific is expected to be the fastest-growing region in the immunoassay market report during the forecast period. The regions covered in the immunoassay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
